文献速递呼吸危重症与机械通气肺栓塞与肺血管病

靶向轻度高碳酸血症对院外心脏骤停后右心室功能的影响:TAME试验子研究

The Effects of Targeted Mild Hypercapnia on Right Ventricular Function After Out-of-Hospital Cardiac Arrest: A Substudy of the Targeted Therapeutic Mild Hypercapnia After Resuscitated Cardiac Arrest Trial.
PubMed 文献 · Chest · 2025-11-24

该单中心预计划子研究纳入111例院外心脏骤停(OHCA)患者,随机分为轻度高碳酸血症组(Paco2 50-55 mm Hg)与正常碳酸血症组(Paco2 35-45 mm Hg)24小时。结果显示高碳酸血症组右心室收缩功能障碍和右心衰竭发生率均低于正常碳酸血症组,且右心衰竭与6个月死亡率升高相关。

要点

  • OHCA后靶向轻度高碳酸血症未恶化右心室功能,反而减少右心室功能障碍和衰竭。
  • 高碳酸血症组右心室收缩功能障碍25%,正常碳酸血症组64%(P < .001)。
  • 右心衰竭与6个月死亡率增加相关(HR 2.89;95% CI 1.37-6.10;P = .005)。

核心结论

  • 在OHCA复苏后患者中,与正常碳酸血症相比,靶向轻度高碳酸血症与右心室功能恶化无关,反而与更少的右心室功能障碍和衰竭相关。
  • OHCA后右心衰竭与6个月死亡率增加相关。

研究设计与样本

  • TAME试验的单中心、预计划子研究,患者随机接受轻度高碳酸血症(Paco2 50-55 mm Hg)或正常碳酸血症(Paco2 35-45 mm Hg)24小时。
  • 共111例患者随机并接受超声心动图评估,其中84例进行了右心导管检查。
  • 在ICU入院后、干预期间及干预后行经胸超声心动图,并在可行时行时间匹配的右心导管检查。

主要发现

  • ICU入院时两组TAPSE均降低且相似。
  • 干预期间,高碳酸血症组的TAPSE、S'和FAC均高于正常碳酸血症组(P < .05)。
  • 高碳酸血症组13例(25%)存在右心室收缩功能障碍,正常碳酸血症组37例(64%)(P < .001)。
  • 右心衰竭共30例:高碳酸血症组8例,正常碳酸血症组22例(P = .011)。
  • 右心衰竭与6个月死亡率增加相关(HR 2.89;95% CI 1.37-6.10;P = .005)。

关键数值与推荐

  • 轻度高碳酸血症目标Paco2 50-55 mm Hg,正常碳酸血症目标Paco2 35-45 mm Hg,持续24小时。
  • 右心室收缩功能障碍定义:TAPSE、S'和FAC三项测量中两项低于异常阈值。
  • 右心衰竭定义:右心室收缩功能障碍合并心脏指数< 2.0 L/min/m2且中心静脉压> 12 mm Hg。

临床怎么用

  • 对OHCA后接受有创机械通气的患者,可考虑靶向轻度高碳酸血症(Paco2 50-55 mm Hg)以减轻右心室功能障碍和衰竭。
  • 应监测OHCA后右心室功能,右心衰竭提示6个月死亡风险增加。

局限性

  • 单中心预计划子研究,样本量有限(111例超声评估,84例右心导管)。
  • 右心导管仅在可行时进行,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Targeting hypercapnia during invasive mechanical ventilation with subsequent respiratory acidosis may impair right ventricular (RV) function and cause RV failure. RV dysfunction is common after cardiac arrest and may be associated with poor outcomes. RESEARCH QUESTION: Does targeting mild hypercapnia after out-of-hospital cardiac arrest (OHCA) adversely affect RV function, and is RV failure after OHCA associated with increased mortality? STUDY DESIGN AND METHODS: In this single-center, preplanned substudy of the Targeted Therapeutic Mild Hypercapnia After Resuscitated Cardiac Arrest (TAME) trial, patients were randomized to mild hypercapnia (Paco2, 50-55 mm Hg) or normocapnia (Paco2, 35-45 mm Hg) for 24 hours. Transthoracic echocardiography was performed shortly after ICU admission, during and after the intervention period. Time-matched right heart catheterization (RHC) was performed when available. RV systolic function was assessed with tricuspid annular plane systolic excursion (TAPSE), S', and fractional area change (FAC), with 2 of 3 measurements less than abnormal thresholds defined as dysfunction. RV failure was defined as RV systolic dysfunction combined with a cardiac index of < 2.0 L/min/m2 and central venous pressure of > 12 mm Hg. RESULTS: A total of 111 patients were randomized and evaluated with echocardiography. RHC was performed in 84 patients. TAPSE similarly was reduced in both treatment groups at ICU admission. During the intervention, TAPSE, S', and FAC were higher in the hypercapnia group (P < .05). Accordingly, 13 patients (25%) in the hypercapnia group demonstrated RV systolic dysfunction compared with 37 patients (64%) in the normocapnia group (P < .001). RV failure was present in 30 patients: 8 patients in the hypercapnia group and 22 patients in the normocapnia group (P = .011). RV failure was associated with increased 6-month mortality (hazard ratio, 2.89; 95% CI, 1.37-6.10; P = .005). INTERPRETATION: Among patients resuscitated from OHCA, targeting mild hypercapnia compared with normocapnia was not associated with worsened RV function, but rather with less RV dysfunction and failure. RV failure was associated with increased 6-month mortality. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov; No.: NCT03114033; URL: www. CLINICALTRIALS: gov.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Melberg MB, Rootwelt SD, Flaa A, et al. The Effects of Targeted Mild Hypercapnia on Right Ventricular Function After Out-of-Hospital Cardiac Arrest: A Substudy of the Targeted Therapeutic Mild Hypercapnia After Resuscitated Cardiac Arrest Trial. Chest. 2025. PMID: 41297587. doi:10.1016/j.chest.2025.11.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。